{
  "basic_data": [
    {
      "cell_line_alt_name": "M05-42",
      "cell_type": "iPSC",
      "frozen": "True",
      "hpscreg_name": "UOWi007-A"
    }
  ],
  "generator": [
    {
      "group": "Illawarra Health and Medical Research Institute, University of Wollongong"
    }
  ],
  "contact": [
    {
      "first_name": "Lezzanne",
      "e_mail": "lezanne@uow.edu.au",
      "last_name": "Ooi",
      "group": "Illawarra Health and Medical Research Institute, University of Wollongong"
    }
  ],
  "publications": [
    {
      "last_author": "Lezanne Ooi",
      "year": "2020.0",
      "first_author": "Rachelle Balez",
      "doi": "10.1016/j.scr.2020.101701",
      "journal": "Stem Cell Research",
      "pmid": "101701",
      "title": "The mRNA-based reprogramming of fibroblasts from a SOD1E101G familial ALS patient to induced pluripotent stem cell line UOWi007"
    }
  ],
  "donor": [
    {
      "sex": "Male",
      "age": "A40_44",
      "disease_description": "Familial ALS; SOD1E101G mutation",
      "disease_name": "Amyotrophic Lateral Sclerosis"
    }
  ],
  "genomic_modifications": [
    {
      "description": "SOD1E101G mutation",
      "loci_name": "SOD1",
      "mutation_type": "VA"
    }
  ],
  "induced_derivation": [
    {
      "i_source_cell_origin_term": "Skin",
      "non_int_vector_name": "mRNA-based reprogramming with Oct4, Klf4, Sox2, c-Myc, Lin28 and Nanog",
      "i_source_cell_type_term": "Fibroblasts",
      "non_int_vector": "Other"
    }
  ],
  "ethics": [
    {
      "institutional_HREC": "University of Wollongong Human Research Ethics Committee",
      "ethics_number": "HE13/272"
    }
  ],
  "culture_medium": [
    {
      "co2_concentration": "0.05"
    }
  ]
}